Shenmai Injection Improves Hypertensive Heart Failure by Inhibiting Myocardial Fibrosis via TGF- β 1/Smad Pathway Regulation
ConclusionMyocardial fibrosis is the main pathological manifestation of hypertensive heart failure, and Shenmai Injection could inhibit myocardial fibrosis and effectively improve heart failure by regulating TGF- β 1/Smad signaling pathway.
Source: Chinese Journal of Integrative Medicine - Category: Internal Medicine Source Type: research
More News: Cardiology | China Health | Diets | Heart | Heart Failure | Internal Medicine | Nutrition | Sodium Chloride | Study